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Abstract 
Benzophenone-3 (2-hydroxy-4-methoxybenzophenone; BP-3) is a UV filter used in a variety of 
personal care products for protection of human skin and hair from damage by ultraviolet radiation. 
BP-3 is suspected to exhibit endocrine disruptive properties. Indeed, it was found able to interact 
with the endocrine system causing alteration of its homeostasis, with consequent adverse health 
effects. Moreover, it is ubiquitously present in the environment, mostly in aquatic ecosystems, with 
consequent risks to the health of aquatic organisms and humans. In the present study, we analysed 
the cytogenetic effects of BP-3 on human lymphocytes using in vitro chromosomal aberrations and 
micronuclei assays. Lymphocyte cultures were exposed to five concentrations of BP-3 (0.20, 0.10, 
0.05, 0.025 and 0.0125 µg/mL) for 24 and 48 hrs (for chromosomal aberrations and micronuclei 
tests, respectively). The concentration of 0.10 µg/mL represents the ADI/TDI reference dose 
established by EU, whereas 0.20, 0.05, 0.025 and 0.0125 µg/mL represent multiple and sub-
multiple of this concentration value. Our results reported, for the first time in literature, the 
cytogenetic effects of BP-3 on cultured human lymphocytes in terms of increased micronuclei and 
chromosomal aberrations frequencies at all tested concentrations, including concentrations lower 
than those established by EU. Vive versa, after 48-h exposure, a significant reduction of the CBPI 
value in cultures treated with BP-3 was not observed, indicating that BP-3 does not seem to produce 
effects on the proliferation/mitotic index when its concentration is equal or less than 0.20 µg/mL.  
 
Keywords:  
BP-3, endocrine disruptors, genotoxicology.  
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Abbreviations 
 
Ab.C = Aberrant Cell 
AF = Acentric Fragments  
BP = Benzophenone  
BP-1 = 2,4- dihydroxybenzophenone 
BP-8 = 2,2′-dihydroxy-4-methoxybenzophenone 
BP-2 = 2,2′,4,4′-tetrahydroxybenzophenone  
4-OH-BP = 4-hydroxybenzophenone 
B’ = chromatid breaks  
B’’ = chromosome breaks 
bw = body weight 
CAs = Chromosomal Aberrations  
CBPI = Cytokinesis-Block Proliferation Index  
Dic = Dicentrics 
EU = European Union  
EFSA = European Food Safety Authority 
FCS = Foetal Calf Serum 
KCl = Potassium chloride 
MNs = Micronuclei  
OECD = Organization for Economic Co-operation and Development 
R = Rings 
Re = Rearrangements 
TDI = Tolerable Daily Intake  
TR = tri- or tetra-radials  
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Introduction 
UV filters are widely used in sunscreens and personal care products, such as cosmetics and 
shampoos, for the protection of skin and hair from UV irradiation (Chisvert et al., 2012; 
Asimakopoulos et al., 2014). They are also present as chemical ingredients of insecticides, 
agricultural chemicals and pharmaceuticals (Careghini et al., 2015), as well as they are used to coat 
surfaces exposed to sunlight, including some food packaging (Vione et al., 2013).  
Benzophenone (BP)-type chemicals are one of the primary components in the UV-filter family, 
detected at high concentrations in biological fluids of different populations worldwide distributed 
(Calafat et al., 2008; Wang and Kannan, 2013). 
The 2-Hydroxy-4-methoxybenzophenone (BP-3), also known as oxybenzone, is a compound 
naturally occurs in flower pigments that can adsorb sunlight in the UVA and UVB regions (French, 
1992). For this reason and for its limited phototransformation, it is one of the most commonly-used 
chemical components in sunscreen and cosmetic products (Careghini et al., 2015; Kim and Choi, 
2014), found in 59% of sunscreens in the United States (Dewalque et al., 2014). BP-3 is also 
employed as photostabiliser in food packaging materials, to prevent polymer photochemical 
degradation, in the treatment of photodermatitis, as well as in plastic surface coatings and polymers 
(Vione et al., 2013).  
However, from ecological point of view, the increasing use of UV filters constitutes a potential risk 
for the environment. Indeed, these filters are often inert in traditional wastewater treatment 
processes, and thus have the potential to contaminate the reclaimed water system, natural water 
bodies and drinking water resources (Xiao et al., 2013). Moreover, these chemicals are also directly 
released into surface waters through swimming, bathing, leaching of land and house coatings. As 
final result, BP-3 and other UV-filter components were detected in several environmental matrices 
such as in surface and tap waters and in sediments (Balmer et al., 2005, Kameda et al., 2011; Gago-
Ferrero et al., 2011). In particular, BP3 has been detected at levels of up to some µg/L in raw 
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wastewater, at tens to several hundreds ng/L in treated wastewater, up to a hundred ng/L in lake 
water and at ng/g levels in solid matrices and in biota (Vione et al., 2013). 
Humans are exposed to BP-type UV filters largely through dermal absorption. Because of the 
extensive use in personal care products, BP-3 and its metabolic derivatives, such as 2,4- 
dihydroxybenzophenone (BP-1), 2,2′,4,4′-tetrahydroxybenzophenone (BP-2), 2,2′-dihydroxy-4-
methoxybenzophenone (BP-8), and 4-hydroxybenzophenone (4-OH-BP), were found widely in 
various human bodily fluids, such as urine (Calafat et al., 2008; Kunisue et al., 2012; Wolff et al., 
2007), breast milk (Ye et al., 2008a), blood (Ye et al., 2008b), and semen (León et al., 2010).  
In particular, these compounds have been reported in urines of a high percentage of subjects from 
many countries, including United States (Calafat et al., 2008; Philippat et al., 2015; Wang and 
Kannan, 2013), China (Wang and Kannan, 2013; Zhang et al., 2013), and Europe (Asimakopoulos 
et al., 2014; Philippat et al., 2012).  
To date, the reproductive and developmental toxicity of BP-type UV filters has been revealed in 
some animal and human studies. A few BP-type UV filters, BP-3 included, have been suspected to 
have endocrine disrupting effects, with consequent alterations in the reproductive system and with 
in vitro and in vivo estrogenic and anti-androgenic effects (Schlumpf et al., 2001; Suzuki et al., 
2005). For example, BP-3 was found able to affect the reproduction of fish (Bluthgen et al., 2012; 
Gago-Ferrero and Diaz-Cruz, 2012) and other aquatic organisms, such as the crustacean Daphnia 
magna (Fent et al., 2010) and the chlorophyte microalgae Scenedesmus vacuolatus (Rodil et al., 
2009), as well as was found able to induce vitellogenin and impairment of reproduction in rainbow 
trout and in Japanese medaka (Coronado et al., 2008). Moreover, after oral administration of 
benzophenone, a significant increase of the incidence of mononuclear-cell leukaemia, 
hepatoblastoma and hepatocellular carcinoma in male mice and histiocytic sarcoma in female mice 
was observed (IARC, 2013). 
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In humans, BP-type UV filters have been linked to various endocrine and reproductive disorders, 
such as reducted couple fecundity and semen quality (Buck Louis et al., 2014, 2015), birth 
outcomes (Wolff et al., 2008), uterine leiomyoma (Pollack et al., 2015) and endometriosis (Kunisue 
et al., 2012).  
The Council of Europe reported maximum BP-3 levels of 0.5 mg/kg for beverages and 2 mg/kg for 
foods (IARC, 2013). The European Food Safety Authority estimated a dietary exposure to 
benzophenone in the European Union (EU) and in the USA correspondent to 23 and 11 µg per 
capita per day, respectively (IARC, 2013). Based on published toxicological data, the EU 
established a temporary tolerable daily intake (TDI) and an acceptable daily intake (ADI) for BP-3 
of 0.1 mg/kg bw (Conseil of Europe, 2009). 
From the genetic and cytogenetic point of view, some studies evidenced that BP-type UV-filters 
were able to induce mutagenic effects in Salmonella (Zeiger et al., 1987), sister chromatid 
exchanges and chromosomal aberrations (CAs) in Chinese hamster ovarian cells (French, 1992). 
However, no data are reported in literature about in vitro cytogenetic effects of BP-3 on human 
lymphocytes. For this reason, in the present study we assessed the possible in vitro clastogenic and 
aneugenic effects of BP-3 exposure on human lymphocyte cells, by CAs and micronuclei (MNs) 
assays.  
The CAs assay allows the detection of cells carrying unstable aberrations (chromosome and 
chromatid breaks, deletions, fragments, rings, dicentrics and chromatid exchanges) that will lead to 
cell death during proliferation, an thus represents a useful test for the detection of potential 
clastognic effects of xenobiotics. MNs represent acentric chromosomal fragments or whole 
chromosomes left behind during mitotic cell division and appear in the cytoplasm of interphase 
cells as small additional nuclei.
 
With respect to the CAs assay, the MNs assay allows the detection 
of both potential clastogenic (chromosome breakage) or aneugenic (chromosome lagging due to 
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dysfunction of mitotic apparatus) effects of different xenobiotics. Interestingly, previous published 
studies provided strong evidence in support of the hypothesis that high CAs and MNs frequencies 
in peripheral blood lymphocytes are powerful predictors of cancer risk (Bonassi et al., 2004) and 
are positively associated with early events in carcinogenesis (Bonassi et al., 2011). 
 
Methods 
Chemicals and Media 
The IUPAC name of Oxybenzone (CAS n. 131-57-7) is 2-Hydroxy-4-methoxybenzophenone.  
The BP-3 was dissolved in Dimethyl Sulfoxide (DMSO, CAS no. 67-68-5). Gibco RPMI 1640 cell 
culture media supplemented with L-glutamine, foetal calf serum, phytohemagglutinin (PHA), and 
antibiotics were purchased from Invitrogen-Life Technologies, Milan, Italy. Cytochalasin-B, 
Mitomycin-C (MMC), DMSO, BP-3 and Giemsa stain solution were obtained from Sigma-Aldrich, 
Milan, Italy. Methanol, Acetic acid, and conventional microscope slides were purchased from Carlo 
Erba Reagenti, Milan, Italy. Potassium chloride (KCl) and Sörensen
 
buffer were obtained from 
Merck S.p.A., Milan, Italy. Vacutainer blood collection tubes were from Terumo Europe, Rome, 
Italy.  
 
Subjects 
Peripheral venous blood was collected from 5 healthy subjects (2 males and 3 females, mean 
age±S.D., 31.50±14.39), non-smoking, non-alcoholic, not under drug therapy, and with no recent 
history of exposure to mutagens. Informed consent was obtained from all blood donors. The study 
was approved by the Univeristy of Turin ethics committee and was performed in accordance with 
the ethical standards laid down in the 1964 Declaration of Helsinki.  
 
Blood Sample Collection and Lymphocyte cultures 
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Heparinized blood samples were obtained by venipuncture and collected in heparinised tubes, for 
genotoxicity testing. All blood samples were coded, cooled (4°C), and processed within 2 h after 
collection. Heparinized venous blood (0.3 mL) was cultured in 25 cm
2
 flasks in 6 mL of RPMI-
1640 medium supplemented with 20% foetal calf serum (FCS), 2% of the mitogenic agent PHA, L-
glutamine (2 mM), antibiotics (100 IU/mL penicillin, and 100 µg/mL streptomycin). The cultures 
were incubated for 72 h at 37°C, under 5% of CO2 in the air in a humidified atmosphere. After 24 h 
of incubation, BP-3 dissolved in DMSO (for stock solution preparation 200 µg of BP-3 were 
dissolved in 1 mL of DMSO) was added to the cultures to a final concentrations of 0.20 µg/mL, 
0.10 µg/mL, 0.05 µg/mL, 0.025 µg/mL and 0.0125 µg/mL. The concentration at 0.10 µg/mL 
represents the Tolerable Daily Intake (TDI) concentration established by European Union (0.1 
mg/Kg BW) for this compound (Councile of Europe, 2009); 0.20 µg/mL is a multiple of the TDI, 
whereas 0.05, 0.025 and 0.0125 µg/mL represent sub-multiple of this value, tested in order to 
determine the genotoxicity threshould limit.  
Three control cultures were assessed: 1) positive control, by adding only MMC (final concentration 
0.1 µg/mL culture); 2) solvent control, by adding only 0.1% of DMSO; 3) negative control, culture 
without both BP-3 and DMSO. Only for MNs assay, after 44 h of incubation, cytochalasin-B was 
added to the cultures at a concentration of 6 µg/mL to block cytokinesis. After 48 h (for CAs assay) 
and 72 h (for MNs assay) of incubation at 37°, the cells were collected by centrifugation and treated 
for 10 min with a pre-warmed mild hypotonic solution (75 mM KCl). After centrifugation and 
removal of the supernatant, the cells were fixed with a fresh mixture of methanol/acetic acid (3:1 
v/v). The treatment with the fixative was repeated three times. Finally, the supernatant was 
discarded and the pellet, dissolved in a minimal volume of fixative, was seeded on the slides to 
detect CAs and MNs by conventional staining with 5% Giemsa (pH 6.8) prepared in Sörensen
 
buffer. 
 
Cytokinesis-Block Micronucleus Assay  
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Microscope analysis was performed at 40X magnification on a light microscope (Dialux 20, Leica, 
Germany). MNs were scored in 1,000 binucleated lymphocytes with well-preserved cytoplasm per 
subject (total 5,000 binucleated cells per concentration), following the established criteria for MNs 
evaluation (Fenech et al., 2003). A total of 1,000 lymphocytes per donor per concentration were 
scored to evaluate the percentage of cells with 1-4 nuclei. The cytokinesis-block proliferation index 
(CBPI) was calculated, according to the following formula: 
[1 × N1] + [2 × N2] + [3 × (N3 + N4)]/N, where N1–N4 represents the number of cells with 1-4 
nuclei, respectively, and N is the total number of cells scored. 
 
Chromosomal Aberrations Assay  
Microscope analysis was performed at 1000X magnification on a light microscope (Dialux 20, 
Leica, Germany). Althogh the Organization for Economic Co-operation and Development (OECD) 
guidelines call for 100 metaphases to be scored for each dose (OECD, 2015), in order to obtain 
results more significant and suitable for statistical analysis, it is the normal practice in our 
laboratory to score 200 metaphases per subject per dose. Thus, in the present work, for each subject 
and BP-3 concentration, 200 well-spread first-division complete metaphases (for a total of 1000 
metaphases for each dose) were analysed for the following categories of CAs: gaps, chromatid 
breaks (B’), chromosome breaks (B”), dicentrics (Dic), rings (R), tri- or tetra-radials (TR), acentric 
fragments (AF), rearrangements (Re) and numerical aberrations. Cells containing one of more types 
of CAs were scored as "aberrant cell” (Ab.C).  
With regard to the opportunity to include gaps in the statistical analyses, the discussion is open. 
Although some authors considered gaps as the appropriate indicator of genotoxic potential of 
chemicals (Savage, 2004), the molecular mechanism of BP-3 to induce achromatic lesion/gaps is 
yet to be revealed. Thus, in our statistical analyses we decided to exclude gaps. The criteria for 
distinguishing chromatide breaks from gaps were the acentric piece displaced with respect to the 
chromosome axis and the size of the discontinuity, which exceeded the width of the chromatide. A 
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dicentric with an acentric fragment was scored as one aberration.  
 
Statistical analysis 
Comparison of mean values of the percentage of cells with MNs, CBPI and CAs between 
exposition levels and their controls was assessed by the non-parametric Mann-Whytney test. 
Statistical calculations were carried out using the SPSS software package program (version 23.0, 
Inc., Chicago, IL, USA). All P values were two tailed, and P values of 5% or less were considered 
statistically significant for all tests carried out. 
 
Results 
 
Effect of BP-3 on CAs formation 
Table 1 shows values of CAs found in the human peripheral lymphocytes cultured in the presence 
of different concentrations of BP-3. BP-3 was found to induce seven types of structural CAs (gaps, 
chromatid and chromosome breaks, dicentric chromosomes, rings, tri- or tetraradials, acentric 
fragments and rearrangements). The most frequent observed aberrations were acentric fragments 
and chromatid aberrations, respectively, wheras no numerical aberrations were found. 
Data obtained indicated that human lymphocytes treated in vitro with BP-3 significantly increased 
the CAs and Ab.C frequencies at all tested concentrations when compared with the solvent control, 
including the lower concentration of 0.0125 µg/mL that represents an eighth of the TDI value 
established by EU for this substance. Moreover, a dose-effect was observed since the regresson 
analysis revealed a significant (P<0.001) correlation between the BP-3 concentrations and the level 
of gemomic damage (Table 3). 
No significant differences were found between the DMSO solvent-control and the negative control 
(P = 0.142), whereas the cultures treated with the known mutagen MMC showed a significant 
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increase of CAs and Ab.C with respect to all BP-3 tested concentrations (P < 0.05), including the 
negative and solvent control cultures (P = 0.008 and P = 0.009, respectively). 
 
Effect of BP-3 on MNs formation 
To verify both the aneugenic and clastogenic effects of BP-3, the MN test was assessed in parallel 
with CAs test (Table 2). Similarly to what we already observed with the CAs assay, our results 
indicated that BP-3 significantly increased the MNs formation at all concentrations tested, including 
both 0.10 µg/mL, that represents the TDI established by EU for this substance, and 0.0125 µg/mL 
that represents an eighth of this limit value. Also in this case, a dose-effect was observed since the 
regresson analysis revealed a significant (P<0.001) correlation between the BP-3 concentrations 
and the frequencies of MNs and Cells with MNs (Table 3). 
The DMSO solvent-control cultures did not show any difference with the negative controls (P = 
0.126), further confirming that at this low concentration DMSO has no cytogenetic effects 
evaluable by MN test. Similarly to what we observed with CAs assay, cultures treated with the 
mutagen MMC showed a significant increase in the MNs formation compared with the negative 
control (P = 0.008), solvent controls (P = 0.008) and all tested concentrations of BP-3 (P = 0.009 
for all concentrations). Finally, after 48-h exposure, a significant reduction of the CBPI value in 
cultures treated with BP-3 was not observed, indicating that at the tested concentrations, BP-3 does 
not seem to produce effects on the proliferation/mitotic index, as confirmend by the regression 
analysis (Tables 2 and 3). 
 
Discussion 
BP-3 is widely used as sunscreen for protection of human skin and hair from damage by ultraviolet 
radiation. It has been found in many cosmetic products and its production and use has been rapidly 
increasing over the past decade. As consequence of this increased production, BP-3 was found to 
have a wide presence in aquatic environments, affecting the water quality and, consequently, the 
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human health. For these reasons, it is considered as a personal care product of emerging 
environmental concern and its concentration limits, in the final products for human consumption, 
are now regulated by the United States Food and Drug Administration and the European 
Commision.  
Here, we discuss data obtained from our in vitro study conducted in order to establish the 
clastogenic and aneugenic potential of BP-3 on human cultured lymphocytes. The results obtained 
with CAs and MNs assays, evidenced a possible clastogenic effect of the BP-3 on human 
lymphocytes, also at the concentration of 0.0125 µg/mL that represents a value eight times lower 
with respect to the reference dose established for humans by EU (Conseil of Europe, 2009).
  
This 
increased cytogenetic damage observed at all tested concentrations pushes towards the adoption of 
more safe concentration for human health with respect to the established value of 0.1 µg/mL. 
Indeed, increased CAs and MNs frequencies in peripheral blood lymphocytes have been positively 
associated with increased cancer risk and early vents in carcinogenesis, respectively (Bonassi et 
al., 2004; 2011).
  
The genotoxicity of BP-type UV-filters has previously been observed by in vivo and in vitro studies 
using non-human organisms and cell systems (Zeiger et al., 1987; French, 1992). However, beyond 
these old reports, no pubblications are present in literature about the possible in vitro clastogenic 
effect of BP-3 on human lymphocytes. For this reason, we cannot compare our data with other 
similar data.  
Notably, for BP-3 we observed a clastogenic effect also at the lower concentrations of 0.025 and 
0.0125 µg/mL, whereas for the BP-A, another endocrine disruptor compound with a very similar 
molecular weight to that of BP-3, we failed to found it (Santovito et al., 2017). This more acute 
effect of BP-3 with respect of BP-A has been observed, by our group, also in in vivo experiments 
conducted using the marine polychaete Ophryotrocha diadema. In this case, we found an increased 
mortality and a lower production of eggs among polychaete treated with the same concentrations of 
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BP-3 used in the present study, compared to those treated with identical BP-A concentrations (data 
not showed).  
The clastogenic properties of the BP-3 could be ascribed to its demonstrated ability to generate 
ROS, probably by decreasing the activities of antioxidant enzymes and increasing lipid 
peroxidation (Wnuk et al., 2017). Indeed, Hunson et coll. (2006) demonstred that BP-3 and other 
UV-filters are able to penetrate through the stratum corneum and to generate higly reactive oxygen 
species in the cytoplasm of the epidermic nucleated keratinocytes.  
Moreover, the demonstrated accessibility of the BP-3 to the labile hydrogens within the DNA 
(Marazzi et al., 2016) could be another possible explanation of this observed clastogenic effect, as 
well as of the increased levels of genomic damage observed for BP-3 with respect to BP-A. This is 
an important issue because increased levels of genomic damage were associated with an increased 
risk of cancer development (Bonassi et al., 2004; 2011), and in particular BP-3 was found able to 
increase metastatic potential in lung cancer cells (Phiboonchaiyanan et al., 2017). 
Although recent studies on BP-3 have demonstrated its cytotoxicity properties (Balázs et al., 2016) 
and its capacity to activate apoptosis (Wnuk et al., 2017), in the present study we did not observed a 
significant reduction of the CBPI, indicating that BP-3 does not seem to produce effects on the 
proliferation/mitotic index when its concentration is equal or less than 0.20 µg/mL (Tables 2 and 3).  
Finally, it should be also emphasized that the observed cytogenetic damage cannot be ascribed 
exclusively to the direct effect of BP-3 on lymphocytes. Indeed, in vitro studies showed that BP-3 
is converted to more hydrophilic and DNA-binding metabolites, such as BP-1, BP-2, BP-8 and 4-
OH-BP (Buck Louis et al., 2014). In this scenario, the irreversible binding of BP-3 derived 
compounds to the DNA could cause bases loss from the DNA strand and could be responsible for 
some of the BP-3 observed toxic effects. It is known that many chemicals, either directly or after 
conversion to reactive metabolites, covalently modify nucleosides of DNA, leading to mutational 
changes ans, thus, playing a role in cellular toxicity or tumorigenesis induction (Atkinson and Roy, 
1995). 
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Conclusion 
The results herein reported demonstrate, for the first time in literature, the clastogenic and 
aneugenic effects of BP-3 on cultured human lymphocytes, by increasing CAs and MNs 
frequencies also at lower concentrations with respect to those established by European Union.  
It should be emphasized that this observed in vitro genotoxic potential on human lymphocytes does 
not seems to manifest itself in in vivo experiments using animal models like drosophila and rat 
(Robison et al., 1994). However, although simple experimental models, like mammalian and 
bacterial cells, cannot accurately mimic the complex kinetics of xenobiotic compounds in vivo, our 
results suggest the need for further investigations about this compound and, eventually, the 
adoption of more stringent measures in order to reduce the presence of this compound in the 
environment and to minimize the adverse effects of the BP-3 exposure on human health.  
 
Acknowledgment 
We are grateful to all volunteers who participated in this study. 
 
Conflict of Interest 
The authors report no conflicts of interest.  
 
Funding 
This research was supported by grant from the Italian Ministry of University and Scientific 
Research (“ex 60%”). 
Page 14 of 23
URL: http:/mc.manuscriptcentral.com/ldct  Email: rcc0022@auburn.edu
Drug and Chemical Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
 15
References 
1) Asimakopoulos, A.G., Thomaidis, N.S., and Kannan, K., 2014. Widespread occurrence of 
bisphenol A diglycidyl ethers, p-hydroxybenzoic acid esters (parabens), benzophenone type-
UV filters, triclosan, and triclocarban in human urine from Athene, Grece. Science of the 
Total Environmen, 470-471, 1243-1249.  
2) Atkinson, A and Roy. D., 1995. In vitro conversion of environmental estrogenic chemical 
bisphenol A to DNA binding metabolite(s). Biochemical and Biophysical Reserch 
Communication, 210(2), 424-433. 
3) Balázs, A., et al., 2016. Hormonal activity, cytotoxicity and developmental toxicity of UV 
filters. Ecotoxicology and Environmental Safety, 131, 45-53. 
4) Balmer, M.E., et al., 2005. Occurrence of some organic UV filters in wastewater, in surface 
waters, and in fish from Swiss lakes. Environmental Science & Technology, 39, 953-962 
5) Blüthgen, N., Zucchi, S., and Fent, K., 2012. Effects of the UV filter benzophenone-3 
(oxybenzone) at low concentrations in zebrafish (Danio rerio). Toxicology and Applied 
Pharmacology 263, 184-194. 
6) Bonassi, S., et al., 2004. Chromosomal aberrations and risk of cancer in humans: an 
epidemiologic perspective. Cytogenetic and Genome Research. 104, 376-382. 
7) Bonassi, S, El-Zein, R. and Bolognesi, C., 2011. Micronuclei frequency in peripheral blood 
lymphocytes and cancer risk: evidence from human studies. Mutagenesis 26, 93-100. 
8) Buck Louis, G.M., et al., 2014. Urinary Concentrations of Benzophenone-Type Ultraviolet 
Radiation Filters and Couples’ Fecundity. American Journal of Epidemiology, 180(12), 
1168-1175 
9) Buck Louis, G.M., et al., 2015. Urinary concentrations of benzophenone-type ultra violet 
light filters and semen quality. Fertility and Sterility, 104, 989-996. 
10) Calafat, A.M., et al., 2008. Concentrations of the sunscreen agent benzophenone-3 in 
residents of the United States: National Health and Nutrition Examination Survey 2003-
Page 15 of 23
URL: http:/mc.manuscriptcentral.com/ldct  Email: rcc0022@auburn.edu
Drug and Chemical Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
 16
2004. Environmental Health and Perspectives, 116, 893-897. 
11) Careghini, A., et al., 2015. Bisphenol A, nonylphenols, benzophenones, and benzotriazoles 
in soils, groundwater, surface water, sediments, and food: a review. Environmental Science 
and Pollution Research, 22, 5711-5741. 
12) Chisvert, A., et al., 2012. An overviewof the analytical methods for the determination of 
organic ultraviolet filters in biological fluids and tissues. Analytica Chimica Acta, 752:11-
29. 
13) Concil of Europe-Report (2009).  Policy Statement Concerning paper and board materials 
and articles intended to come into contact with foodstuffs. Version 4, pag. 21. Available on 
https://rm.coe.int/CoERMPublicCommonSearchServices/DisplayDCTMContent?documentI
d=09000016804e4794 accessed in date 07-29-2017. 
14) Coronado, M., et al., 2008.  Estrogenic activity and reproductive effects of the UV-filter 
oxybenzone (2-hydroxy-4-methoxyphenyl-methanone) in fish. Aquatic Toxicolofgy, 90(3), 
182-187. 
15) Dewalque, L., et al., 2014. Simultaneous determination of some phthalate metabolites, 
parabens and benzophenone-3 in urine by ultra high pressure liquid chromatography tandem 
mass spectrometry. Journal of Chromatography B, 949–950, 37–47. 
16) Fenech, M., et al., 2003. HUman MicronNucleus project (HUMN project): detailed 
description of the scoring criteria for the cytokinesis-block micronucleus assay using 
isolated human lymphocyte cultures. Mutation Research, 534(1-2), 65-75. 
17) Fent, K., et al., 2010. A tentative environmental risk assessment of the UV-filters 3-(4-
methylbenzylidene-camphor), 2-ethyl-hexyl-4-trimethoxycinnamate, benzophenone-3, 
benzophenone-4 and 3-benzylidene camphor.  Marine Environmental Research, 69(1), S4–
S6. 
18) French, J.E., 1992. NTP Technical Report on Toxicity Studies of 2-hydroxy-4-methoxy-
benzophenone. (1992) National Toxicology Report No. 21, NIH Publication No. 92, 1-52, 
Page 16 of 23
URL: http:/mc.manuscriptcentral.com/ldct  Email: rcc0022@auburn.edu
Drug and Chemical Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
 17
available at https://ntp.niehs.nih.gov/ntp/htdocs/st_rpts/tox021.pdf. Accessed in date 07-29-
2017. 
19) Gago-Ferrero, P., Díaz-Cruz, M.S., and Barceló, D., 2011. Fast pressurized liquid extraction 
with in-cell purification and analysis by liquid chromatography-tandem mass spectrometry 
for the determination of UV filters and their degradation products in sediments. Analytical 
and Bioanalytical Chemistry, 400, 2195-2204. 
20) Gago-Ferrero,P., and Diaz-Cruz, M.S., 2012. An overview of UV-absorbing compounds 
(organic UV filters) in aquatic biota. Analytical and Bioanalytical Chemistry, 404, 2597-
2610. 
21) Hanson, K.M., Gratton, E., and Bardeen, C.J., 2006. Sunscreen enhancement of UV-induced 
reactive oxygen species in the skin. Free Radical Biology and Medicine 41, 1205-1212. 
22) Kameda, Y., Kimura, K., and Miyazaki, M., 2011. Occurrence and profiles of organic sun-
blocking agents in surface waters and sediments in Japanese rivers and lakes. Environmental 
Pollution, 159(6), 1570-1576. 
23) Kim, S., and Choi, K. 2014. Occurrences, toxicities, and ecological risk of benzophenone-3, 
a common component of organic sunscreen products: a mini-review. Environmental 
International, 70:143-157. 
24) Kunisue, T., et al., 2012. Urinary concentrations of benzophenone-type UV filters in U.S. 
women and their association with endometriosis. Environmental Science & Technology, 46, 
4624-4632. 
25) International Agency for Research on Cancer (IARC). (2013) Some Chemicals Present in 
Industrial and Consumer Products, Food and Drinking Water. 101, 285-304. 
26) León, Z., et al., 2010. Solid-phase extraction liquid chromatography–tandem mass 
spectrometry analytical method for the determination of 2-hydroxy-4-
methoxybenzophenone and its metabolites in both human urine and semen. Analytical and 
Bioanalytical Chemistry, 398, 831-843. 
Page 17 of 23
URL: http:/mc.manuscriptcentral.com/ldct  Email: rcc0022@auburn.edu
Drug and Chemical Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
 18
27) Marazzi, M., et al., 2016. Hydrogen abstraction by photoexcited benzophenone: 
consequences for DNA photosensitization. Physical Chemistry Chemical Physics. 18, 7829-
7836. 
28) OECD (Organization for Economic Co-operation and Development). Guidance Documents 
on Revisions to OECD Genetic Toxicology Test Guidelines. 
https://www.oecd.org/env/ehs/testing/Draft Guidance Document on OECD Genetic 
Toxicology Test Guidelines.pdf. 2015; 31. Accessed in date 07-29-2017. 
29) Phiboonchaiyanan, P., et al., 2017. Benzophenone-3 increases metastasis potential in lung 
cancer cells via epithelial to mesenchymal transition. Cell Biology and Toxicology, 33, 251-
261. 
30) Philippat, C., et al., 2012. Exposure to phthalates and phenols during pregnancy and 
offspring size at birth. Environmental Health Perspectives, 120, 464-470. 
31) Philippat, C., et al., 2015. Exposure to select phthalates and phenols through use of personal 
care products among Californian adults and their children. Environmental Research, 140, 
369-376. 
32) Pollack, A.Z., et al., 2015. Bisphenol A, benzophenone-type ultraviolet filters, and 
phthalates in relation to uterine leiomyoma. Environmental Research, 137, 101-107. 
33) Robison, S.H., et al., 1994. Assessment of the in vivo genotoxicity of 2-hidroxy 4-
methoxybenzophenone. Environmental and Molecular Mutagenesis, 23(4):312-317. 
34) Rodil, R., et al., 2009. Photostability and phytotoxicity of selected sunscreen agents and 
their degradation mixtures in water. Analytical and Bioanalytical Chemistry, 395(5), 1513-
1524. 
35) Santovito, A., Cannarsa, E., Schleicherova, D. and Cervella, P. (2017) Clastogenic effects of 
bisphenol A on human cultured lymphocytes. Human & Experimental Toxicology, Jan 
1:960327117693069. doi: 10.1177/0960327117693069. [Epub ahead of print] 
36) Savage, J.R., 2004. On the nature of visible chromosomal gaps and breaks. Cytogenetics 
Page 18 of 23
URL: http:/mc.manuscriptcentral.com/ldct  Email: rcc0022@auburn.edu
Drug and Chemical Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
 19
and Genome Research, 104(1-4): 46-55. 
37) Schlumpf, M., et al., 2001. In vitro and in vivo estrogenicity of UV screens. Environmental 
Health Perspectives, 109, 239-244. 
38) Suzuki, T., et al., 2005. Estrogenic and antiandrogenic activities of 17 benzophenone 
derivatives used as UV stabilizers and sunscreens. Toxicology and Applied Pharmacology, 
203, 9-17. 
39) Vione, D., et al., 2013. Phototransformation of the sunlight filter benzophenone-3 (2-
hydroxy-4-methoxybenzophenone) under conditions relevant to surface waters. Science of 
the Total Environment, 463-464, 243-251. 
40) Wang, L., and Kannan, K. (2013). Characteristic profiles of benzophenone-3 and its 
derivatives in urine of children and adults from the United States and China. Environmental 
Science & Technology, 47, 12532–12538. 
41) Wnuk, A., et al., 2017. Apoptosis Induced by the UV Filter Benzophenone-3 in Mouse 
Neuronal Cells Is Mediated via Attenuation of Erα/Pparγ and Stimulation of Erβ/Gpr30 
Signaling. Moleculkar Neurobiology, 1-22 early view. doi: 10.1007/s12035-017-0480-z. 
42) Wolff, M.S., et al., 2007. Pilot study of urinary biomarkers of phytoestrogens, phthalates, 
and phenols in girls.  Environmental Health Perspectives, 115, 116-121. 
43) Wolff, M.S., et al., 2008. Prenatal phenol and phthalate exposures and birth outcomes. 
Environmental Health Perspectives, 116, 1092-1097. 
44) Xiao, M., et al., 2013.
 
Transformation mechanism of benzophenone-4 in free chlorine 
promoted chlorination disinfection.  Water Research, 47(16), 6223-6233. 
45) Ye, A.M. et al., 2008 a. Automated on-line column-switching HPLC–MS/MS method with 
peak focusing for measuring parabens, triclosan, and other environmental phenols in human 
milk. Analytica Chimica Acta, 622, 150-156. 
46) Ye, X., et al., 2008 b. Automated on-line column-switching HPLC–MS/MS method for 
measuring environmental phenols and parabens in serum. Talanta, 76, 865-871. 
Page 19 of 23
URL: http:/mc.manuscriptcentral.com/ldct  Email: rcc0022@auburn.edu
Drug and Chemical Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
 20
47) Zhang, T., et al., 2013. Benzophenone-type UV filters in urine and blood from children, 
adults, and pregnant women in China: partitioning between blood and urine as well as 
maternal and fetal cord blood. Science of the Total Environment, 461-462, 49–55. 
48) Zeiger, E., et al., 1987. Salmonella mutagenicity tests: III. Results from the testing of 255 
chemicals. Environmental Mutagenesis 9(9), 1-109. 
Page 20 of 23
URL: http:/mc.manuscriptcentral.com/ldct  Email: rcc0022@auburn.edu
Drug and Chemical Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Table 1 - Induction of chromosomal aberrations by 2-Hydroxy-4-methoxybenzophenone in human lymphocytes in vitro. 
CAs = chromosomal aberrations; Ab.C = aberrant cells (cells with 1 ore more aberrations); NC = Negative Control; MMC = Mitomycin-C; 
BP-3 = 2-Hydroxy-4-methoxybenzophenone; B’: chromatid break; B’’: chromosome break; DC: dicentric; R: ring; TR = tri-tetraradials; AF = acentric 
fragments; Re = rearrangements; S.E. = standard error.  
a 
Significantly different with respect to DMSO control solvent P = 0.009; 
b
 Significantly different with respect to DMSO control solvent P = 0.008; 
c
 
Significantly different with respect to DMSO control solvent P = 0.043  
 
 
Test 
substance 
 
Treatment 
Period      Dose 
  (h)         (µg/ml) 
  
Total 
Scored 
Metaphases 
CAs 
 
Gaps      B’       B’’    DC      R      TR      AF      Re 
Total 
CAs 
Total 
CAs 
+ 
Gaps 
Total 
Ab.C 
Total 
Ab.C 
+ 
Gaps 
CAs/Cell ± S.E. 
(%) 
Ab.C/Cell ± S.E. 
(%) 
NC  ---- ---- 1000 5 6 0 1 0 0 8 0 15 21 15 21 1.500±0.158  1.500±0.158 
0.1% DMSO  24 ---- 1000 10 9 0 2 0 0 8 2 21 31 21 31 2.100±0.367 2.100±0.367 
MMC  24 0.10 1000 39 37 31 12 8 18 21 17 144 183 136 175 14.400±1.336 
a
 13.600±1.177 
a
 
BP-3  24 0.20 1000 32 32 21 5 3 0 24 16 101 133 99 131 10.100±0.510 
b
 9.900±0.400 
 b
 
BP-3  24 0.10 1000 22 32 11 4 4 1 26 15 93 115 93 115 9.300±0.875 
 b
 9.300±0.875 
 b
 
BP-3  24 0.05 1000 13 21 11 2 0 0 24 16 74 87 71 84 7.400±1.308 
 b
 7.100±1.134 
 b
 
BP-3  24 0.025 1000 13 20 7 2 2 0 31 11 73 85 72 85 7.300±1.446 
 b
 7.200±1.347 
 b
 
BP-3 24 0.0125 1000 10 11 5 0 1 0 17 1 35 45 35 45 3.500±0.548 
 c
 3.500±0.548 
 c
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Table 2 – Induction of micronuclei by 2-Hydroxy-4-methoxybenzophenone in human lymphocytes in vitro. 
 
Test 
substance 
Treatment 
Period      Dose 
    (h)       (µg/ml) 
BNCs 
scored 
Distribution of BNCs 
according to the 
number of MNs 
 1       2        3        4 
MNs Ab.C MNs/cell ± S.E. (%) 
 
Ab.C/cell ± S.E. 
(%) CBPI ± S.E 
NC ---- ---- 5000 11 0 0 0 11 11 0.220±0.000 0.220±0.000 1.732±0.025 
0.1% DMSO 48 ---- 5000 16 0 0 0 16 16 0.320±0.000 0.320±0.000 1.811±0.062 
MMC 48 0.10 5000 135 12 8 0 183 155 3.660±0.005 a 2.675±0.003 1.345±0.020 
BP3 48 0.20 5000 69 4 0 0 77 73 1.540±0.001 a 1.525±0.002 a 1.684±0.017 
BP3 48 0.10 5000 70 4 1 0 81 75 1.620±0.002 a 1.425±0.002 a 1.603±0.041 
BP3 48 0.05 5000 44 1 0 0 46 45 0.920±0.001 a 0.850±0.001 a 1.690±0.033 
BP3 48 0.025 5000 41 3 0 0 47 44 0.940±0.001 b 0.880±0.001 b 1.696±0.029 
BP3 48 0.0125 5000 31 1 0 0 33 32 0.660±0.002 c 0.640±0.002 c 1.710±0.067 
BNCs = Binucleated cells; MNs = micronuclei; Ab.C = Aberrant cells (cells with 1 or more MNs); NC = Negative Control;  
MMC = Mitomycin-C; BP-3 = 2-Hydroxy-4-methoxybenzophenone; S.E. = Standard Error. CBPI = Cytokinesis-Block Proliferation Index.  
a
 Significantly differ with respect to DMSO control solvent P = 0.008; b Significantly differ with respect to DMSO control solvent P = 0.011;  
c
  Significantly differ with respect to DMSO control solvent P = 0.025 
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Table 3 - Multiple regression analysis evaluating the relationship between BP-3 concentrations 
and the level of genomic damage 
 
Biomarkers β-co P-value 95% CI 
(Lower) – (Upper) 
CAs 
Cells with CAs 
MNs 
Cells with MNs 
CBPI 
0.705 
0.723 
0.690 
0.724 
0.227 
<0.001 
<0.001 
<0.001 
<0.001 
0.274 
(1.719) – (4.361) 
(1.751) – (4.209) 
(1.335) – (3.545) 
(1.332) – (3.188) 
(-0.041) – (-0.012) 
CAs = Chromosomal Aberrations; MNs = micronuclei; CBPI = 
Cytokinesis-Block Proliferation Index; β-co = β-coefficient;  
CI = Confidence Interval 
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